{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-264658","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.503170+00:00","generated_at":"2026-05-17T00:36:04.024633+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Soleno reports Q3 net income $26M, first profitable quarter; VYKAT XR revenue $66M","bullets":["Product revenue of $66.0M from VYKAT XR launch (first revenue, vs $0 prior year); net income $26.0M ($0.47 diluted EPS) vs net loss of $76.6M in Q3 2024.","1,043 patient start forms and 764 active patients on VYKAT XR as of Sept 30, 2025; 494 unique prescribers and over 132M lives covered since March approval.","Cash and securities at $556.1M, including $230M gross proceeds from July common stock offering; operating cash flow of $43.5M in Q3.","Sequential product revenue more than doubled from $32.7M in Q2 2025; R&D expense fell to $8.4M from $30.1M, and SG&A to $33.8M from $49.2M.","Appointed Mark W. Hahn to Board of Directors and Audit Committee; contingent consideration liability for Essentialis earnout estimated at $19.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-264658","json":"https://secwatch.observer/filing/0001193125-25-264658.json","markdown":"https://secwatch.observer/filing/0001193125-25-264658.md","text":"https://secwatch.observer/filing/0001193125-25-264658.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312525264658/0001193125-25-264658-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312525264658/d58763d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:36:04.024633+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}